Bayer Aktiengesellschaft (VIE:BAYN)

Market Cap	28.61B
Revenue (ttm)	46.17B
Net Income (ttm)	-3.42B
Shares Out	n/a
EPS (ttm)	-3.48
PE Ratio	n/a
Forward PE	6.17
Dividend	0.11 (0.38%)
Ex-Dividend Date	Apr 28, 2025

Volume	n/a
Average Volume	1,081
Open	29.22
Previous Close	29.14
Day's Range	29.22 - 29.22
52-Week Range	18.22 - 30.55
Beta	n/a
RSI	61.16
Earnings Date	Nov 12, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin...

• Industry: Chemicals and Allied Products
• Founded: 1863
• Employees: 91,864
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: BAYN

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.